Wakefit Innovations Ltd
NSE: WAKEFIT BSE: 544642
Incorporated in 2016, Wakefit Innovations Limited is a Indian D2C (Direct-to-Consumer) home and sleep solutions company.[1]
₹152
52W: ₹119 — ₹224
PE 0 · Book ₹0 · +0% vs bookMarket Cap₹5,007 Cr
Stock P/E—Price to Earnings
ROCE1.53%Return on Capital
ROE8.2%Return on Equity
Div. Yield0%Face Value ₹1
Weaknesses
- −Company has low interest coverage ratio.
- −Promoter holding has decreased over last quarter: -0.36%
- −Company has a low return on equity of -14.4% over last 3 years.
- −Earnings include an other income of Rs.31.7 Cr.
Shareholding Pattern
Promoters37.03%
FIIs15.38%
DIIs26.61%
Public20.97%
| Category | Dec 2025 | Mar 2026 |
|---|---|---|
| Promoters | 37.39% | 37.03%▼0.4 |
| FIIs | 19.54% | 15.38%▼4.2 |
| DIIs | 22.44% | 26.61%▲4.2 |
| Public | 20.62% | 20.97%▲0.3 |
Financial Statements
| Metric | Dec 2024 | Sep 2025 | Dec 2025 |
|---|---|---|---|
| Sales | 385 | 377 | 421 |
| Expenses | 365 | 336 | 362 |
| Operating Profit | 20 | 41 | 59 |
| OPM % | 5% | 11% | 14% |
| Net Profit | -2 | 16 | 32 |
| EPS ₹ | -2.29 | 1.01 | 0.97 |
AI Insights
Revenue Trend
Mar 2025 revenue at ₹1,274Cr, up 29.2% YoY. OPM at 5%.
Debt Position
Borrowings at ₹277Cr. Debt-to-equity ratio: 0.51x. Moderate leverage.
Margin & Efficiency
ROCE declining from 0% (Mar 2021) to -2% (Mar 2025). Working capital days: 45.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2d - Wakefit to host Q4 FY26 earnings call on May 22, 2026 at 9:30 a.m. IST.
- Board Meeting Intimation for Considering And Approving The Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026. 15 May - Board meeting on May 21, 2026 to consider audited FY26 financial results; trading window closed from April 1.
- Compliances-Reg.24(A)-Annual Secretarial Compliance 8 May - Wakefit filed FY26 Annual Secretarial Compliance Report; no non-compliances or penalties observed.
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 8 May - CARE Ratings reported nil deviation in Q4FY26 IPO and pre-IPO fund utilisation.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 8 May
- Transcript
- PPT